Menarini Receives FDA Orphan Drug Designation for SEL24/MEN170...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
FLORENCE, Italy, Nov. 4, 2021 /PRNewswire-AsiaNet/ -- The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for the treatment of Acute Myeloid Leukemia (AML). SEL24/MEN1703 is a first-in-class, orally available, dual...
Authors: LATEST ASIANET NEWS RELEASES